Alex Rogers, Executive Producer of the International Cannabis Business Conference and The Talman Group and MC Jamie Pearson, International Consultant, New Holland Group, welcome conference attendees and provide an overview of the conference schedule, including the panels and speakers that will be providing presentations and interviews.

Succeeding in the emerging global cannabis industry requires hard work, dedication, ingenuity, and the ability to navigate a regulatory landscape that is constantly evolving. It is an industry that is truly unlike any other large industry on the planet, and the potential financial rewards are significant. Verdant Strategies Partner Mike Goral J.D., LL.M will provide opening remarks to kick off the Talman conference curriculum and will discuss how his company has helped numerous clients turn regulatory complexity into clarity. Mr. Goral is recognized as a leading authority in the global cannabis industry and is the author of ‘Multistate Cannabis Taxation’ for Thomson Reuters, the definitive resource on the subject. With more than a decade dedicated exclusively to helping cannabis operators, he has guided companies through tax, accounting, and operational complexities while helping many entities scale from single retail locations into thriving multi-market organizations.

TBA

The United Kingdom is the second-largest legal medical cannabis market in Europe, and yet it is also largely untapped. This panel presentation will examine who the major players are in the UK market, what role telemedicine plays in the UK, and discuss whether domestic production will meet future demand or if imports will still be a significant component of the nation’s supply chain. Panelists will also provide current patient demand data and projections for how many potential patients the UK market will have in the future, and with it, insight for the best potential opportunities for cannabis investors to focus on as the legal UK patient base expands.

As the year 2025 draws to a close, industry members are looking toward 2026 and contemplating the many questions and unknowns facing the cannabis space. This panel of leading industry experts will explore trends in Europe’s major markets, including opportunities in new markets and assessing which established markets may be facing potential rollbacks and restrictions in 2026.

True Terpenes’ formulations are used in more than $9 billion worth of consumer packaged goods every year, with the company’s products being infused into industry-leading beverages and wellness products around the globe. That scale gives a clear perspective: the companies that thrive in this industry are those that embrace science, safety, and sensory consistency as their growth engines. As one of the only terpene companies whose products are currently able to be included in EU GMP-certified products, True Terpenes enjoys both the badge of compliance and proof that its approach to sensory science and safety is aligned with the highest pharmaceutical benchmarks in the world. True Terpenes CEO Dan Cook will share how European operators who embrace science and compliance as a competitive advantage will define the future of the industry in this intimate discussion with Talman founder Alex Rogers.

The emerging legal cannabis industry is transitioning from individual siloed markets to a network of international industries. As the legal industry continues to expand globally, new merger, acquisition, and investment opportunities are being created around the world. David Hyde from Hyde Advisory & Investments Inc. will examine current industry trends and provide an update on recent M&A and investment transactions across the global cannabis industry.

Medical cannabis products and cannabis-derived products are becoming more common in European pharmacies, which is paralleled by an evolution in how the historical pharmaceutical industry views cannabis as medicine. This panel of subject matter experts will discuss how the pharmaceutical cannabis sector may differentiate itself from the wider European medical cannabis market. The panel will also provide factors for investors to consider, how investors can best position themselves in the cannabis pharmaceutical market, and examples of recent investments.

Join us for an exclusive fireside chat with Raj Grover, CEO of High Tide, one of North America’s largest cannabis retailers and now a key player in Europe. Fresh off the company’s acquisition of Remexian Pharma in Germany, Raj will share how he evaluates global opportunities, why Germany matters, and what’s next for European cannabis. Expect candid insights into market timing, investment signals, and the values that drive him as a leader. This is a must-attend session for anyone weighing the future of cannabis in Europe.

This pitch session will involve presentations from four different companies, each with immense potential in the cannabis space. The Talman House portfolio provides a range of opportunities, from pure startups to operators with established distribution channels and market traction. Companies from Europe and around the world will be represented in these rapid-fire presentations, with eight (8) minute pitches followed by seven (7) minute Q&A sessions.